Cochlear Implant Outcomes in Large Vestibular Aqueduct Syndrome-Should We Provide Cochlear Implants Earlier?
Authors of this article are:
Hall AC, Kenway B, Sanli H, Birman CS.
A summary of the article is shown below:
OBJECTIVE: Examine postoperative speech perception outcomes in a large vestibular aqueduct syndrome (LVAS) patients at a major cochlear implantation center.STUDY DESIGN: Retrospective analysis of the Sydney Cochlear Implant Centre (SCIC) database and medical records from January 1994 to December 2015 was performed.SETTING: Tertiary referral center.PATIENTS: Patients with a diagnosis of LVAS who received a cochlear implant (CI). Only those with speech perception outcomes recorded at least 12 months post implant were included in our analysis.INTERVENTION(S): Therapeutic.MAIN OUTCOME MEASURE(S): Postoperative speech perception scores.RESULTS: Between 1994 and 2015, 176 adult and pediatric patients with a diagnosis of LVAS underwent cochlear implantation at SCIC. Postoperative Bamford-Kowal Bench (BKB) sentence test scores were obtained for 97 patients. The postoperative median BKB score was 93% with a lower quartile score of 85% and an upper quartile score of 98%. Smaller numbers were available for post-CI City University of New York (CUNY) and Consonant-Nucleus-Consonant (CNC) word scores yet similar excellent results were seen.CONCLUSIONS: Our study results suggest the CI should be considered when BKB scores have dropped to 85%. We suggest that rather than LVAS cases representing a challenge to cochlear implantation, they are amongst the best candidates for surgery, and should receive a CI at an earlier stage in hearing loss, when they have better speech perception. This allows stable hearing to be established earlier along with excellent speech perception outcomes.
Check out the article’s website on Pubmed for more information:
This article is a good source of information and a good way to become familiar with topics such as: n/a.
New Chemicals from MOLECULAR DEPOT
Triglyceride Mix for Interference Testing
Microparticle Stabilizer Solution
Enzyme Acceptor Stabilization Buffer
Enzyme Donor Stabilization Buffer
Progesterone Biotin Conjugate Solution
Microparticle Activation Buffer
Microparticle Washing Buffer
Microparticle Blocking Buffer
Microparticle Anti Aggregation Agent
CPRG (Chlorophenol red-β-D-galactopyranoside)
New Antibodies from MOLECULAR DEPOT
Antibody to Thyroxine T4 Monoclonal
SAA Antibody Monoclonal Anti-Serum Amyloid A
Valproic Acid Antibody (Mouse Monoclonal)
Phenytoin Antibody (Mouse Monoclonal)
Anti Sheep IgG (H+L) Rabbit Polyclonal
Anti Human IgM Antibody Polyclonal
Myoglobin Antibody (Human Affinity Purified)
Rheumatoid Factor Interference Blocker
HAMA Blocking Reagent (Affinity Purified)
New Proteins from MOLECULAR DEPOT
Tacrolimus BSA Conjugate Solution
Cholesterol Oxidase from Streptomyces sp.
Aprotinin from Bovine Lung (Lyophilized powder)
Beta-galactosidase Enzyme Donor
Beta-galactosidase Enzyme Acceptor
Xanthine Oxidase Grade II (Lyophilized Powder)
Ascorbate Oxidase (Lyophilized Powder)
Silk Fibroin (Bombyx Mori Silkworm)
Fibrinogen from Bovine Plasma Lyophilized
Horseradish Peroxidase Biotinylated
New Research Kits from MOLECULAR DEPOT
Interference Test Kit
Alpha Complementation Kit Beta-galactosidase
Crystallization Screen for Protein-DNA Complexes
NativeFolder Bacterial Culture Medium
CycloScreen: Cyclodextrins Kit for Screening
NativePro Bradford Protein Assay Kit (Automated)
Rheumatoid Factor Interference Kit
Interference Test Kit EXTRA
HAMA Interference Kit
ELISA Microplate Production Kit